nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Dacarbazine—muscle cancer	0.139	0.671	CbGbCtD
Phenylephrine—CYP1A2—Etoposide—muscle cancer	0.068	0.328	CbGbCtD
Phenylephrine—Skin necrosis—Etoposide—muscle cancer	0.0402	0.0507	CcSEcCtD
Phenylephrine—Skin necrosis—Methotrexate—muscle cancer	0.0241	0.0304	CcSEcCtD
Phenylephrine—Extravasation—Dactinomycin—muscle cancer	0.0222	0.028	CcSEcCtD
Phenylephrine—Skin necrosis—Doxorubicin—muscle cancer	0.0208	0.0263	CcSEcCtD
Phenylephrine—Rales—Methotrexate—muscle cancer	0.0205	0.0259	CcSEcCtD
Phenylephrine—Sensitisation—Doxorubicin—muscle cancer	0.0204	0.0257	CcSEcCtD
Phenylephrine—Extravasation—Vincristine—muscle cancer	0.0199	0.0251	CcSEcCtD
Phenylephrine—Extravasation—Etoposide—muscle cancer	0.0161	0.0203	CcSEcCtD
Phenylephrine—Skin exfoliation—Etoposide—muscle cancer	0.0134	0.0169	CcSEcCtD
Phenylephrine—Lacrimation—Doxorubicin—muscle cancer	0.0124	0.0156	CcSEcCtD
Phenylephrine—Keratitis—Doxorubicin—muscle cancer	0.0112	0.0142	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00984	0.0124	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—muscle cancer	0.00964	0.0122	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Vincristine—muscle cancer	0.00956	0.0121	CcSEcCtD
Phenylephrine—Myocardial infarction—Vincristine—muscle cancer	0.0095	0.012	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—muscle cancer	0.00899	0.0113	CcSEcCtD
Phenylephrine—Sweating increased—Etoposide—muscle cancer	0.00858	0.0108	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—muscle cancer	0.00835	0.0105	CcSEcCtD
Phenylephrine—Cardiac disorder—Vincristine—muscle cancer	0.00808	0.0102	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00806	0.0102	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—muscle cancer	0.00803	0.0101	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—muscle cancer	0.0079	0.00996	CcSEcCtD
Phenylephrine—Angiopathy—Vincristine—muscle cancer	0.0079	0.00996	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vincristine—muscle cancer	0.00784	0.00989	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Etoposide—muscle cancer	0.00774	0.00976	CcSEcCtD
Phenylephrine—Myocardial infarction—Etoposide—muscle cancer	0.0077	0.00971	CcSEcCtD
Phenylephrine—Mental disorder—Vincristine—muscle cancer	0.00762	0.00962	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—muscle cancer	0.00751	0.00947	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—muscle cancer	0.00749	0.00944	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—muscle cancer	0.00737	0.00929	CcSEcCtD
Phenylephrine—Agitation—Vincristine—muscle cancer	0.00696	0.00878	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—muscle cancer	0.00695	0.00877	CcSEcCtD
Phenylephrine—Cardiac disorder—Etoposide—muscle cancer	0.00654	0.00825	CcSEcCtD
Phenylephrine—Hypertension—Vincristine—muscle cancer	0.00654	0.00825	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—muscle cancer	0.00648	0.00817	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—muscle cancer	0.00644	0.00812	CcSEcCtD
Phenylephrine—Angiopathy—Etoposide—muscle cancer	0.0064	0.00807	CcSEcCtD
Phenylephrine—Immune system disorder—Etoposide—muscle cancer	0.00637	0.00803	CcSEcCtD
Phenylephrine—Mediastinal disorder—Etoposide—muscle cancer	0.00635	0.00801	CcSEcCtD
Phenylephrine—Nervous system disorder—Vincristine—muscle cancer	0.00606	0.00765	CcSEcCtD
Phenylephrine—Dysgeusia—Etoposide—muscle cancer	0.00601	0.00758	CcSEcCtD
Phenylephrine—Hyperhidrosis—Vincristine—muscle cancer	0.00598	0.00754	CcSEcCtD
Phenylephrine—Pain—Dactinomycin—muscle cancer	0.00592	0.00746	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—muscle cancer	0.00585	0.00738	CcSEcCtD
Phenylephrine—Paraesthesia—Vincristine—muscle cancer	0.00555	0.007	CcSEcCtD
Phenylephrine—Loss of consciousness—Etoposide—muscle cancer	0.00539	0.0068	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00534	0.00673	CcSEcCtD
Phenylephrine—Hypertension—Etoposide—muscle cancer	0.0053	0.00668	CcSEcCtD
Phenylephrine—Pain—Vincristine—muscle cancer	0.00529	0.00667	CcSEcCtD
Phenylephrine—Chest pain—Etoposide—muscle cancer	0.00523	0.00659	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00519	0.00654	CcSEcCtD
Phenylephrine—Hypersensitivity—Dactinomycin—muscle cancer	0.0051	0.00643	CcSEcCtD
Phenylephrine—Tachycardia—Etoposide—muscle cancer	0.00489	0.00617	CcSEcCtD
Phenylephrine—Skin disorder—Etoposide—muscle cancer	0.00487	0.00614	CcSEcCtD
Phenylephrine—Hyperhidrosis—Etoposide—muscle cancer	0.00484	0.00611	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00483	0.00609	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00483	0.00609	CcSEcCtD
Phenylephrine—Hypersensitivity—Vincristine—muscle cancer	0.00456	0.00575	CcSEcCtD
Phenylephrine—Paraesthesia—Etoposide—muscle cancer	0.0045	0.00567	CcSEcCtD
Phenylephrine—Dyspnoea—Etoposide—muscle cancer	0.00447	0.00563	CcSEcCtD
Phenylephrine—Vomiting—Dactinomycin—muscle cancer	0.0044	0.00555	CcSEcCtD
Phenylephrine—Rash—Dactinomycin—muscle cancer	0.00436	0.0055	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00432	0.00545	CcSEcCtD
Phenylephrine—Pain—Etoposide—muscle cancer	0.00428	0.0054	CcSEcCtD
Phenylephrine—Nausea—Dactinomycin—muscle cancer	0.00411	0.00518	CcSEcCtD
Phenylephrine—Dizziness—Vincristine—muscle cancer	0.00409	0.00516	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—muscle cancer	0.00407	0.00513	CcSEcCtD
Phenylephrine—Urticaria—Etoposide—muscle cancer	0.00398	0.00502	CcSEcCtD
Phenylephrine—Vomiting—Vincristine—muscle cancer	0.00393	0.00496	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—muscle cancer	0.00392	0.00494	CcSEcCtD
Phenylephrine—Rash—Vincristine—muscle cancer	0.0039	0.00492	CcSEcCtD
Phenylephrine—Dermatitis—Vincristine—muscle cancer	0.0039	0.00491	CcSEcCtD
Phenylephrine—Headache—Vincristine—muscle cancer	0.00387	0.00489	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—muscle cancer	0.00383	0.00483	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—muscle cancer	0.00381	0.00481	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—muscle cancer	0.00381	0.0048	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—muscle cancer	0.00372	0.00469	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—muscle cancer	0.0037	0.00467	CcSEcCtD
Phenylephrine—Hypersensitivity—Etoposide—muscle cancer	0.00369	0.00465	CcSEcCtD
Phenylephrine—Nausea—Vincristine—muscle cancer	0.00367	0.00463	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—muscle cancer	0.0036	0.00454	CcSEcCtD
Phenylephrine—Pruritus—Etoposide—muscle cancer	0.00354	0.00447	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—muscle cancer	0.00352	0.00444	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—muscle cancer	0.00346	0.00437	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—muscle cancer	0.00339	0.00428	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—muscle cancer	0.00332	0.00418	CcSEcCtD
Phenylephrine—Dizziness—Etoposide—muscle cancer	0.00331	0.00418	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—muscle cancer	0.0033	0.00417	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—muscle cancer	0.0033	0.00416	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—muscle cancer	0.00327	0.00412	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—muscle cancer	0.0032	0.00404	CcSEcCtD
Phenylephrine—Vomiting—Etoposide—muscle cancer	0.00318	0.00402	CcSEcCtD
Phenylephrine—Rash—Etoposide—muscle cancer	0.00316	0.00398	CcSEcCtD
Phenylephrine—Dermatitis—Etoposide—muscle cancer	0.00316	0.00398	CcSEcCtD
Phenylephrine—Headache—Etoposide—muscle cancer	0.00314	0.00396	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—muscle cancer	0.00313	0.00395	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—muscle cancer	0.00312	0.00394	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—muscle cancer	0.00312	0.00393	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00311	0.00392	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—muscle cancer	0.00309	0.0039	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—muscle cancer	0.003	0.00378	CcSEcCtD
Phenylephrine—Nausea—Etoposide—muscle cancer	0.00298	0.00375	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—muscle cancer	0.00294	0.00371	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—muscle cancer	0.00293	0.00369	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—muscle cancer	0.00291	0.00368	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—muscle cancer	0.0029	0.00366	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—muscle cancer	0.00285	0.0036	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—muscle cancer	0.00281	0.00355	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—muscle cancer	0.0028	0.00353	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—muscle cancer	0.00275	0.00347	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—muscle cancer	0.00271	0.00342	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—muscle cancer	0.00269	0.0034	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00269	0.00339	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—muscle cancer	0.00267	0.00337	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00259	0.00327	CcSEcCtD
Phenylephrine—Pain—Methotrexate—muscle cancer	0.00257	0.00324	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—muscle cancer	0.00256	0.00322	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—muscle cancer	0.00255	0.00321	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—muscle cancer	0.00254	0.0032	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—muscle cancer	0.00252	0.00318	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00251	0.00317	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—muscle cancer	0.00238	0.00301	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—muscle cancer	0.00233	0.00294	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—muscle cancer	0.00232	0.00292	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00224	0.00283	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—muscle cancer	0.00222	0.0028	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—muscle cancer	0.00221	0.00279	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—muscle cancer	0.00212	0.00268	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—muscle cancer	0.00206	0.0026	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—muscle cancer	0.00198	0.0025	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—muscle cancer	0.00191	0.00241	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—muscle cancer	0.00191	0.00241	CcSEcCtD
Phenylephrine—Rash—Methotrexate—muscle cancer	0.00189	0.00239	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—muscle cancer	0.00189	0.00238	CcSEcCtD
Phenylephrine—Headache—Methotrexate—muscle cancer	0.00188	0.00237	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—muscle cancer	0.00184	0.00232	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—muscle cancer	0.00178	0.00225	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—muscle cancer	0.00172	0.00217	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—muscle cancer	0.00165	0.00208	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—muscle cancer	0.00164	0.00207	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—muscle cancer	0.00164	0.00206	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—muscle cancer	0.00163	0.00205	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—muscle cancer	0.00154	0.00195	CcSEcCtD
